racemetirosine has been researched along with Astrocytoma in 3 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
Excerpt | Relevance | Reference |
---|---|---|
"To develop a valid treatment strategy for recurrent high-grade gliomas using stereotactic hypofractionated reirradiation based on biologic imaging and temozolomide." | 3.73 | Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. ( Franz, M; Grosu, AL; Gumprecht, H; Molls, M; Nieder, C; Piert, M; Schwaiger, M; Stärk, S; Thamm, R; Weber, WA, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riemann, B | 1 |
Papke, K | 1 |
Hoess, N | 1 |
Kuwert, T | 2 |
Weckesser, M | 1 |
Matheja, P | 2 |
Wassmann, H | 2 |
Heindel, W | 1 |
Schober, O | 2 |
Grosu, AL | 1 |
Weber, WA | 1 |
Franz, M | 1 |
Stärk, S | 1 |
Piert, M | 1 |
Thamm, R | 1 |
Gumprecht, H | 1 |
Schwaiger, M | 1 |
Molls, M | 1 |
Nieder, C | 1 |
Woesler, B | 1 |
Morgenroth, C | 1 |
Palkovic, S | 1 |
Schäfers, M | 1 |
Vollet, B | 1 |
Schäfers, K | 1 |
Lerch, H | 1 |
Brandau, W | 1 |
Samnick, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial[NCT01252459] | Phase 2 | 200 participants (Anticipated) | Interventional | 2011-07-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for racemetirosine and Astrocytoma
Article | Year |
---|---|
Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Astrocytoma; Biopsy; Brain; Brain Neoplasms; F | 2002 |
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Topics: Adult; Aged; alpha-Methyltyrosine; Analysis of Variance; Antineoplastic Agents, Alkylating; Astrocyt | 2005 |
Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Topics: Adult; Aged; alpha-Methyltyrosine; Amino Acids; Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; E | 1997 |